Next Science Wound Gel Efficacy in Chronic Wound Versus Standard of Care
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
This is a 3 to 4 months, multi-site, prospective randomized clinical study of patients
diagnosed with a chronic wound. The primary objective is to assess changes in healing rate,
by measuring differences in wound area when treating chronic wounds with the Next Science
Wound Gel compared to the Triple Antibiotic Ointment Neosporin (Standard of Care, SOC). At
the end of the study period, patients may continue receiving their assigned study treatment
provided they have signed the "Continuation of Treatment Informed Consent" and the rational
for continuation is documented by the investigator.
Phase:
N/A
Details
Lead Sponsor:
Next Science TM
Collaborators:
Jacksonville Center For Clinical Research Jacksonville Clinical Research Center Mayo Clinic
Treatments:
Anti-Bacterial Agents Antibiotics, Antitubercular Bacitracin Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination Neomycin Polymyxin B